TNFAIP3 and hepatocellular carcinoma: According to this assay, the expression of MAP2K6 and TNFAIP3 were evidently decreased, while CASP3 expression was significantly increased, in sh-APEX1-treated HCC cells as compared to control-treated cells (Figure 5E).